Home / Countries / Belgium / HIV medicines

Belgium · availability and reimbursement

HIV medicines in Belgium

Of 32 verified HIV medicine records for Belgium, 29 are available and reimbursed (91%), 1 are available but not reimbursed and 2 are not available. 10 further records are still under review.

91% of verified records reimbursed

Last checked 02/11/2026 · This is information only, not advice or a recommendation.

Medicines by status

Available and reimbursed 29

Biktarvy, Celsentri, Delstrigo, Descovy, Dovato, Edurant, Epivir, Eviplera, Generic TDF/FTC (Emtricitabine/Tenofovir DF), Genvoya, Intelence, Isentress, Juluca, Kaletra, Kivexa, Odefsey, Pifeltro, Prezista, Rekambys, Rezolsta, Stribild, Sunlenca, Symtuza, Tivicay, Triumeq, Truvada, Viread, Vocabria, Vocabria / Rekambys

Available, not reimbursed 1

Rukobia

Not available 2

Generic TLD (Tenofovir/Lamivudine/Dolutegravir), Generic TLE (Tenofovir/Lamivudine/Efavirenz)

Under review 10

Apretude, Emtricitabine / Rilpivirine / Tenofovir Alafenamide Viatris, Emtricitabine / Tenofovir alafenamide Viatris, Emtriva, Evotaz, Norvir, Retrovir, Reyataz, Yeytuo, Ziagen

See every medicine with its source →

More about Belgium

PrEPDoxyPEPSexuality educationAbortion and contraceptionMigrant healthcareFull Belgium profile

Neighbouring countries

NetherlandsLuxembourgGermanyFrance

Open the interactive map

Based on public, cited sources and SHAPE's review. Rules and prices change, so please confirm with the national authority or a professional. Found an error? Tell us.